To demonstrate the feasibility of targeted genetically encoded PDT, we then use pseudotyped lentiviral particles, exhibiting a high tropism to human epidermal growth receptor 2 (HER2), to deliver the NanoLuc-miniSOG gene into a HER2-positive tumor, followed by its elimination in the absence of external light. This evidence concerns the gene ERBB2 and neoplasm.